Clinical Trial Update: Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine plus capecitabine for advanced or inoperable cholangiocarcinoma and gallbladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED